Omet Pharma started selling prescription medicine in 2022. Currently Omet Pharma has a portfolio of prescription medicines in oncology, respiratory, CVS and CNS for the Nordic market.

We are building a portfolio in prescription medicine

The initial focus of Omet Pharma is prescription medicine covered by tenders. These products can effectively be commercialised by an experienced and small commercial team; like the Omet Pharma team.​

Branded generics and value-added medicine

Beyond 2023, branded generics and value-added medicine, will be added to the scope of Omet Pharma.

Skip to content